Last update 10 Sep 2026

Darwin Origin (Hubei) Biopharmaceutical Co., Ltd.

Subsidiary Company|2022|Hubei Sheng, China

Overview

Tags

Nervous System Diseases
Cardiovascular Diseases
Other Diseases
Mesenchymal stem cell therapy

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Nervous System Diseases1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Mesenchymal stem cell therapy1

Related

1
Drugs associated with Darwin Origin (Hubei) Biopharmaceutical Co., Ltd.
ALT001(Darwin)
Target-
Mechanism-
Active Org.
Darwin Origin (Hubei) Biopharmaceutical Co., Ltd. [+2]
Originator Org.
Beijing Darwin Cell Biotechnology Co., LtdBeijing Darwin Cell Biotechnology Co., Ltd
Active Indication
Amyotrophic Lateral Sclerosis [+8]
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
6
Clinical Trials associated with Darwin Origin (Hubei) Biopharmaceutical Co., Ltd.
CTR20260590
/ RecruitingPhase 1
评价ALT001 在中国健康受试者中单、多次给药安全性、耐受性的随机、双盲、安慰剂对照，I 期临床研究。
[Translation] A randomized, double-blind, placebo-controlled phase I clinical study to evaluate the safety and tolerability of ALT001 with single and multiple doses in healthy Chinese subjects.
ChiCTR2600119043
/ RecruitingNot ApplicableIIT
A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Tolerability of Single and Multiple Doses of ALT001 in Healthy Chinese Subjects
CTR20254999
/ RecruitingPhase 1
ALT001在肌萎缩侧索硬化症患者中安全性和初步有效性的剂量递增，随机，双盲安慰剂对照，Ⅰ期临床研究。
[Translation] A dose-escalation, randomized, double-blind, placebo-controlled, phase I clinical study of the safety and preliminary efficacy of ALT001 in patients with amyotrophic lateral sclerosis (ALS).
100 Clinical Results associated with Darwin Origin (Hubei) Biopharmaceutical Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Darwin Origin (Hubei) Biopharmaceutical Co., Ltd.
Login to view more data
100 Deals associated with Darwin Origin (Hubei) Biopharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Darwin Origin (Hubei) Biopharmaceutical Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 12 Sep 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
ALT001(Darwin)
Amyotrophic Lateral Sclerosis
More
Phase 2
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free